This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Triamcinolone (Aristocort) and Dexamethasone (Deronil) Preparations in the Therapy of Ocular Inflammation

SHANKAR B. CHAVAN, M.D.; EDWARD J. CUMMINGS, M.D.; THOMAS A. EGAN, M.D.

AMA Arch Ophthalmol. 1960;63(2):319-329.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Scientific research and clinical analysis of the newer adrenal corticosteroids are continuously being carried on to evaluate their ability to suppress inflammation, edema, and allergic reaction, with a minimum of side reactions. These research efforts have resulted in improved topical and systemic cortical steroids that provide higher therapeutic effect with low dosage and a minimum amount of side-effects.

The analogues, triamcinolone, prednisone, and prednisolone, were found to be superior to cortisone and hydrocortisone.^1-5 Experimental studies on uveitis revealed that a given anti-inflammatory response required doses several times greater of cortisone and hydrocortisone than triamcinolone-free alcohol, prednisone, or prednisolone.^1,4,5

The most recent forms of adrenal steroids are triamcinolone (Aristocort) and dexamethasone (Deronil), which have been considered to be the more potent and relatively least toxic of the corticosteroids. Triamcinolone-free alcohol and triamcinolone diacetate are the parent compounds. The three special derivatives of triamcinolone-free alcohol are triamcinolone acetonide, triamcinolone acetonide . . . [Full Text PDF of this Article]

Author Affiliations
Washington, D.C.

From the Eye Research Section, Department of Surgery, Georgetown University Medical Center.; Present address of Dr. Chavan: c/o Shri. N.B. Suryawanshi, Buldana, Bombay State, India.; Research Fellow in Ophthalmology (Dr. Chavan), Professor of Ophthalmology (Dr. Cummings), and Clinical Associate Professor of Ophthalmology (Dr. Egan), Georgetown University Medical Center.

Footnotes
Submitted for publication Oct. 19, 1959.

The Research study related to Triamcinolone (Aristocort) preparations was supported in part through the Medical Research Section (Dr. C. H. Demos), Lederle Laboratories, A Division of Cyanamid Company, Pearl River, N.Y. The research study related to Dexamethasone (Deronil) preparations was also financed through a Division of Clinical Research (Dr. H. V. Pifer), Schering Corporation, Bloomfield, N.J.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?